No warranty against infringement of any patent, copyright or trademark is made or implied. Abbott Laboratories assumes no responsibility for results obtained or for incidental or consequential damages, including lost profits, arising from the use of these data. It is not intended to supplement, modify or supersede any information provided with respect to the medical use of the product. This information is not a substitute for the advice of a healthcare professional, nor is it a recommendation for any particular course of treatment. However, Abbott Laboratories does not guarantee their accuracy or completeness or the recommendations contained herein, NOR SHALL ANY OF THIS INFORMATION CONSTITUTE A WARRANTY, WHETHER EXPRESSED OR IMPLIED, AS TO THE SAFETY OF THE GOODS, THE MERCHANTABILITY OF THE GOODS, OR THE FITNESS OF THE GOODS FOR A PARTICULAR PURPOSE. The information and recommendations contained herein are based upon tests believed to be reliable. The Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) research team were the first to demonstrate how this TBI blood test can be used for the benefit of TBI patients in clinical care.For information regarding lithium batteries in Abbott equipment, please email or call +1-57 Army Medical Materiel Development Activity (USAMMDA), played a critical role in developing the test run on Abbott’s i-STAT TBI platform. Bemærk: Ikke alle produkter er tilgængelige i alle regioner. Check with your local representative for availability in specific markets. Army Medical Research and Development Command’s (USAMRDC) U.S. Note: Not all products are available in all regions. Department of Defense (DoD) – which has been dedicated to developing a solution for the objective detection and evaluation of TBI for more than a decade. The TBI blood test was developed in collaboration with the U.S.
Istat abbott portable#
Our vision for the future is that we’d have a 15-minute, portable test that can be used outside the traditional healthcare setting where people experience head injuries and need a quick evaluation, like sporting events. We are also working on a whole blood test, which would eliminate the need for separation of plasma and could be used at the patient’s side in a healthcare setting. Rapid diagnostic devices like i-STAT TBI allow healthcare workers to triage patients with traumatic brain injuries faster. When hospital stay time is of the essence, having a TBI blood test available could help eliminate wait time in the emergency room and could reduce the number of unnecessary CT scans by up to 40%. And even though concussions from sporting events are on the decline, slips and falls are still occurring, which means there is still a need for concussion diagnosis and treatment. Especially as hospitals near or are at capacity. Time is of the essence during the pandemicĪvoiding the hospital altogether, or getting in and out as quickly as possible, is top of mind for most people during the COVID-19 era.
For those who test positive, this test result complements CT scans to help clinicians evaluate whether someone has a TBI. A negative result on this test can be used to rule out the need for a head CT scan, a common tool used to evaluate concussion. This test measures specific proteins present in the blood after a TBI. TBIs, including concussions, refer to an alteration in brain function, caused by an external force.
Tests results are available within 15 minutes after plasma is placed in the test cartridge. Our i-STAT TBI plasma test is the first rapid handheld traumatic brain injury (TBI) blood test, which will help clinicians assess individuals with suspected mild TBIs, including concussions. The first rapid handheld objective blood test for concussions For a condition that impacts millions annually and poses short-term risk, long-term risk, and even death-objective testing used in tandem with these methods is crucial. Previously, concussions and TBIs have been evaluated through methods such as CT scan, patient questionnaire, or a neurological exam, which, in some cases, are not empirical on their own. The main hurdle to recovery is that these injuries are often undiagnosed or misdiagnosed. However, there has never been an objective method of assessing patients suspected to have sustained these invisible injuries-until now. Methods: We evaluated the agreement of ACT assays using four parallel measurements performed on two commonly used devices each (i.e., two Hemochron Signature Elite (Hemochron) and two Abbott i-STAT (i-STAT) devices, respectively). An estimated 4.8 million emergency room visits per year can be attributed to TBIs, and roughly 40% of all concussions are caused by slips and falls. Traumatic brain injuries (TBI), including concussions, are common, and not only within the sports world.
0 kommentar(er)
